The EU-AIMS Longitudinal European Autism Project (LEAP): clinical characterisation.

Mol Autism 2017 23;8:27. Epub 2017 Jun 23.

Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Kapittelweg 29, 6525 EN Nijmegen, The Netherlands.

Background: The EU-AIMS Longitudinal European Autism Project (LEAP) is to date the largest multi-centre, multi-disciplinary observational study on biomarkers for autism spectrum disorder (ASD). The current paper describes the clinical characteristics of the LEAP cohort and examines age, sex and IQ differences in ASD core symptoms and common co-occurring psychiatric symptoms. A companion paper describes the overall design and experimental protocol and outlines the strategy to identify stratification biomarkers.

Methods: From six research centres in four European countries, we recruited 437 children and adults with ASD and 300 controls between the ages of 6 and 30 years with IQs varying between 50 and 148. We conducted in-depth clinical characterisation including a wide range of observational, interview and questionnaire measures of the ASD phenotype, as well as co-occurring psychiatric symptoms.

Results: The cohort showed heterogeneity in ASD symptom presentation, with only minimal to moderate site differences on core clinical and cognitive measures. On both parent-report interview and questionnaire measures, ASD symptom severity was lower in adults compared to children and adolescents. The precise pattern of differences varied across measures, but there was some evidence of both lower social symptoms and lower repetitive behaviour severity in adults. Males had higher ASD symptom scores than females on clinician-rated and parent interview diagnostic measures but not on parent-reported dimensional measures of ASD symptoms. In contrast, self-reported ASD symptom severity was higher in adults compared to adolescents, and in adult females compared to males. Higher scores on ASD symptom measures were moderately associated with lower IQ. Both inattentive and hyperactive/impulsive ADHD symptoms were lower in adults than in children and adolescents, and males with ASD had higher levels of inattentive and hyperactive/impulsive ADHD symptoms than females.

Conclusions: The established phenotypic heterogeneity in ASD is well captured in the LEAP cohort. Variation both in core ASD symptom severity and in commonly co-occurring psychiatric symptoms were systematically associated with sex, age and IQ. The pattern of ASD symptom differences with age and sex also varied by whether these were clinician ratings or parent- or self-reported which has important implications for establishing stratification biomarkers and for their potential use as outcome measures in clinical trials.

Download full-text PDF

Source Listing
March 2018
71 Reads

Publication Analysis

Top Keywords

asd symptom
symptom severity
measures asd
co-occurring psychiatric
psychiatric symptoms
paper describes
european autism
age sex
inattentive hyperactive/impulsive
symptoms lower
males higher
longitudinal european
lower adults
adults compared
children adolescents
hyperactive/impulsive adhd
heterogeneity asd
project leap
questionnaire measures


(Supplied by CrossRef)

G Baird et al.
Lancet 2006

TS Brugha et al.
Arch Gen Psychiatry 2011

DL Christensen et al.
MMWR Surveill Summ 2016

A Gokoolparsadh et al.
Cell Mol Life Sci 2016

American Psychiatric Association et al.

M-C Lai et al.
PLoS Biol 2013

E Simonoff et al.
J Am Acad Child Adolesc Psychiatry 2008

M-C Lai et al.
Lancet 2014

T Charman et al.

C Lord et al.
Am J Med Genet C: Semin Med Genet 2015

MV LLombardo et al.
Baron-Cohen S. Unsupervised data-driven stratification of mentalizing heterogeneity in autism. Scientific Reports. 2016

Similar Publications